# Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly

> **NCT04938323** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Harvard Medical School (HMS and HSDM)**

## Conditions studied

- Acute Respiratory Infection

## Interventions

- **DRUG:** BCG Vaccine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04938323
- **Lead sponsor:** Harvard Medical School (HMS and HSDM)
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-05
- **Primary completion:** 2022-07
- **Final completion:** 2022-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Covid-19 related delays in project launch
- **Last updated:** 2022-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04938323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04938323, "Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04938323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*